Atrial fibrillation and chronic kidney disease: A bad combination
Márcio Galindo Kiuchi
Kidney Res Clin Pract. 2018;37(2):103-105.   Published online 2018 Jun 30     DOI: https://doi.org/10.23876/j.krcp.2018.37.2.103
Citations to this article as recorded by Crossref logo
Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis
Ioannis Kyriakoulis, Anastasia Adamou, Iliana Stamatiou, David Dimitris Chlorogiannis, Ioannis Kardoutsos, Despoina Koukousaki, George Ntaios
European Journal of Internal Medicine.2024; 119: 45.     CrossRef
Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population‐Based Study
Seon‐Mi Kim, Yujin Jeong, Yae Lim Kim, Minjung Kang, Eunjeong Kang, Hyunjin Ryu, Yunmi Kim, Seung Seok Han, Curie Ahn, Kook‐Hwan Oh
Journal of the American Heart Association.2023;[Epub]     CrossRef
Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
Dolina Gencheva
Journal of Cardiovascular Emergencies.2023; 9(3): 49.     CrossRef
Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink
Natasha Slater, Simon White, Martin Frisher
Journal of Arrhythmia.2023;[Epub]     CrossRef
Epidemiology, thrombolytic management, and outcomes of acute stroke among patients with chronic kidney disease: a systematic review and meta-analysis
Ido Zamberg, Marie Assouline-Reinmann, Emmanuel Carrera, Manish M Sood, Stephen M Sozio, Pierre-Yves Martin, Thomas A Mavrakanas
Nephrology Dialysis Transplantation.2022; 37(7): 1289.     CrossRef
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant
Ahsan A. Khan, Lewis J. Hardy, Eduard Shantsila, Yee C. Lau, Helen Philippou, Gregory Y.H. Lip
Thrombosis Research.2021; 197: 69.     CrossRef
Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta‐analysis
Wei‐Chieh Lee, Po‐Jui Wu, Chih‐Yuan Fang, Huang‐Chung Chen, Mien‐Cheng Chen
International Journal of Clinical Practice.2021;[Epub]     CrossRef
Dialysis Mode and Associated Outcomes in Patients With End‐Stage Renal Disease and Atrial Fibrillation: A 14‐Year Nationwide Cohort Study
Chih‐Hsiang Chang, Pei‐Chun Fan, Yu‐Sheng Lin, Shao‐Wei Chen, Michael Wu, Ming‐Shyan Lin, Cheng‐Hui Lu, Po‐Cheng Chang, Ming‐Jer Hsieh, Chao‐Yung Wang, Chun‐Li Wang, Pao‐Hsien Chu, Victor Chien‐Chia Wu
Journal of the American Heart Association.2021;[Epub]     CrossRef
Dose discordance of direct acting oral anticoagulants using different equations for estimating GFR: a literature review
Morteza Nabiee, Simin Dashti-Khavidaki, Behrouz Khajeh
Expert Review of Clinical Pharmacology.2020; 13(8): 857.     CrossRef
TO DETERMINE THE ROLE OF RANOLAZINE FOR RHYTHM CONTROL STRATEGY IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION- AN OBSERVATIONAL STUDY FROM A TERTIARY CARE CENTER. (RANOVA STUDY)
Praveen Shukla, Awadhesh Kumar Sharma, Biswajit Majumder, Pritam Kumar Chatterjee, Vinay Krishna, Anamika Shukla
GLOBAL JOURNAL FOR RESEARCH ANALYSIS.2020; : 48.     CrossRef
Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects
A. I. Skripka, P. O. Bochkov, K. A. Akmalova, R. V. Shevchenko, P. M. Krupenin, V. V. Kogay, A. I. Listratov, A. S. Krainyaya, D. A. Napalkov, O. S. Gurinovich, A. A. Sokolova, V. V. Fomin, D. A. Sychev
Medical Council.2020; (21): 65.     CrossRef
Approaches for the identification of chronic kidney disease in CPRD–HES-linked studies
Sreeram Ramagopalan, Thomas P Leahy, Elaine Stamp, Cormac Sammon
Journal of Comparative Effectiveness Research.2020; 9(7): 441.     CrossRef
Genome-wide screening of functional long noncoding RNAs in the epicardial adipose tissues of atrial fibrillation
Xin Shi, Xuelian Shao, Ban Liu, Mengwei Lv, Pratik Pandey, Changfa Guo, Ruilin Zhang, Yangyang Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(7): 165757.     CrossRef
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease
Alena Skripka, Dmitriy Sychev, Pavel Bochkov, Roman Shevchenko, Pavel Krupenin, Veronika Kogay, Alexander Listratov, Arina Krainyaya, Olga Gurinovich, Anastasiya Sokolova, Dmitry Napalkov, Viktor Fomin
High Blood Pressure & Cardiovascular Prevention.2020; 27(2): 151.     CrossRef
Prevalence of Advanced Chronic Kidney Disease in Patients with Nonvalvular Atrial Fibrillation Hospitalized in Cardiology Departments
M. I. Chashkina, N. L. Kozlovskaya, D. A. Andreev, N. A. Ananicheva, A. A. Bykova, Z. K. Salpagarova, A. L. Syrkin
Kardiologiia.2020; 60(2): 41.     CrossRef
Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients
Marius Miglinas, Ugne Cesniene, Marta Monika Janusaite, Arturas Vinikovas
Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef